BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yin H, Chen N, Guo R, Wang H, Li W, Wang G, Cui J, Jin H, Hu JF. Antitumor potential of a synthetic interferon-alpha/PLGF-2 positive charge peptide hybrid molecule in pancreatic cancer cells. Sci Rep 2015;5:16975. [PMID: 26584517 DOI: 10.1038/srep16975] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
Number Citing Articles
1 Puckette M, Barrera J, Schwarz M, Rasmussen M. Method for quantification of porcine type I interferon activity using luminescence, by direct and indirect means. BMC Biotechnol 2022;22:13. [PMID: 35351081 DOI: 10.1186/s12896-022-00743-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Xie ZB, Zhang YF, Jin C, Mao YS, Fu DL. LRG-1 promotes pancreatic cancer growth and metastasis via modulation of the EGFR/p38 signaling. J Exp Clin Cancer Res 2019;38:75. [PMID: 30760292 DOI: 10.1186/s13046-019-1088-0] [Cited by in Crossref: 16] [Cited by in F6Publishing: 23] [Article Influence: 5.3] [Reference Citation Analysis]
3 Pian L, Wen X, Kang L, Li Z, Nie Y, Du Z, Yu D, Zhou L, Jia L, Chen N, Li D, Zhang S, Li W, Hoffman AR, Sun J, Cui J, Hu JF. Targeting the IGF1R Pathway in Breast Cancer Using Antisense lncRNA-Mediated Promoter cis Competition. Mol Ther Nucleic Acids 2018;12:105-17. [PMID: 30195750 DOI: 10.1016/j.omtn.2018.04.013] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 4.8] [Reference Citation Analysis]
4 Zhang W, Yu X, Li Y, Su Z, Jandt KD, Wei G. Protein-mimetic peptide nanofibers: Motif design, self-assembly synthesis, and sequence-specific biomedical applications. Progress in Polymer Science 2018;80:94-124. [DOI: 10.1016/j.progpolymsci.2017.12.001] [Cited by in Crossref: 86] [Cited by in F6Publishing: 68] [Article Influence: 21.5] [Reference Citation Analysis]
5 Zhang Y, Hu JF, Wang H, Cui J, Gao S, Hoffman AR, Li W. CRISPR Cas9-guided chromatin immunoprecipitation identifies miR483 as an epigenetic modulator of IGF2 imprinting in tumors. Oncotarget 2017;8:34177-90. [PMID: 27486969 DOI: 10.18632/oncotarget.10918] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 4.3] [Reference Citation Analysis]
6 Wang H, Guo R, Du Z, Bai L, Li L, Cui J, Li W, Hoffman AR, Hu JF. Epigenetic Targeting of Granulin in Hepatoma Cells by Synthetic CRISPR dCas9 Epi-suppressors. Mol Ther Nucleic Acids. 2018;11:23-33. [PMID: 29858058 DOI: 10.1016/j.omtn.2018.01.002] [Cited by in Crossref: 23] [Cited by in F6Publishing: 29] [Article Influence: 5.8] [Reference Citation Analysis]
7 Pang J, Yan X, Cao H, Qian L, He H, Tian H, Han F, Wang G, Chen X, Zhao Y, Hu JF, Cui J. Knockdown of COPS3 Inhibits Lung Cancer Tumor Growth in Nude Mice by Blocking Cell Cycle Progression. J Cancer 2017;8:1129-36. [PMID: 28607586 DOI: 10.7150/jca.16201] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]